AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.300
+0.240 (22.64%)
Nov 20, 2024, 4:00 PM EST - Market closed
AN2 Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 39 | 609 | 185 | - | - | - |
| Market Cap Growth | -93.32% | 229.57% | - | - | - | - |
| Enterprise Value | -55 | 486 | 81 | - | - | - |
| Last Close Price | 1.30 | 20.49 | 9.53 | - | - | - |
| PB Ratio | 0.44 | 4.89 | 1.94 | - | - | - |
| P/TBV Ratio | 0.36 | 4.89 | 1.94 | - | - | - |
| Debt / Equity Ratio | - | - | 0.00 | - | - | 0.15 |
| Quick Ratio | 9.33 | 7.64 | 13.37 | 17.25 | 2.79 | 35.21 |
| Current Ratio | 9.75 | 7.87 | 13.72 | 17.70 | 2.90 | 35.85 |
| Return on Equity (ROE) | -53.56% | -58.83% | -52.08% | -66.64% | -359.68% | - |
| Return on Assets (ROA) | -32.19% | -36.07% | -31.47% | -38.77% | -91.65% | - |
| Return on Capital (ROIC) | -35.72% | -39.54% | -33.58% | -41.71% | -109.80% | - |
| Earnings Yield | -156.46% | -10.62% | -22.15% | - | - | - |
| FCF Yield | -157.37% | -8.74% | -18.10% | - | - | - |
| Buyback Yield / Dilution | -41.95% | -53.85% | -481.46% | -2.71% | -0.62% | - |
| Total Shareholder Return | -41.95% | -53.85% | -481.46% | -2.71% | -0.62% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.